{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:10:05Z","timestamp":1789665005669,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670006"],"award-info":[{"award-number":["81670006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660616"],"award-info":[{"award-number":["81660616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.lfs.2019.01.022","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T20:59:42Z","timestamp":1547585982000},"page":"248-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2\/STAT3 pathway"],"prefix":"10.1016","volume":"219","author":[{"given":"Xingyi","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2019.01.022_bb0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1309\/AJCPAN7BH5DNYWZB","article-title":"B-acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"144","author":"Loghavi","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ejh.12862","article-title":"Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia","volume":"98","author":"Thota","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.lfs.2019.01.022_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-016-0406-z","article-title":"PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value","volume":"35","author":"Xu","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.01.022_bb0020","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/leu.2011.60","article-title":"The serine\/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells","volume":"25","author":"Asano","year":"2011","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.lfs.2019.01.022_bb0025","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/0008-5472.CAN-05-4272","article-title":"Pim-3, a proto-oncogene with serine\/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1158\/1535-7163.MCT-13-0575-T","article-title":"PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2\/3) and CXCR4-mediated microenvironmental interactions (PIM1)","volume":"13","author":"Decker","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"28","key":"10.1016\/j.lfs.2019.01.022_bb0035","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/onc.2009.124","article-title":"Pim-1 plays a pivotal role in hypoxia-induced chemoresistance","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0040","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2004-05-2006","article-title":"Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lfs.2019.01.022_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bjh.13013","article-title":"PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways","volume":"167","author":"Meja","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.lfs.2019.01.022_bb0050","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2013-01-481457","article-title":"Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation","volume":"122","author":"Lu","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lfs.2019.01.022_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12943-015-0477-z","article-title":"Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas","volume":"14","author":"Kreuz","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2019.01.022_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5604\/17322693.1052449","article-title":"Expression of PIM-2 and NF-\u03baB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival","volume":"67","author":"Kapelko-S\u0142owik","year":"2013","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"20","key":"10.1016\/j.lfs.2019.01.022_bb0065","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2015-11-685032","article-title":"Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia","volume":"127","author":"Bellon","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.lfs.2019.01.022_bb0070","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2017-01-760702","article-title":"Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma","volume":"130","author":"Szyd\u0142owski","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood-2009-07-233445","article-title":"A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia\/lymphoma","volume":"115","author":"Lin","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0080","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.3892\/mmr.2017.7215","article-title":"PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3\u03b2","volume":"16","author":"Fan","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0085","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3892\/ijo.2016.3689","article-title":"miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes","volume":"49","author":"Kuang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2019.01.022_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.46","article-title":"Targeting the Pim kinases in multiple myeloma","volume":"5","author":"Keane","year":"2015","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.lfs.2019.01.022_bb0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.lfs.2019.01.022_bb0100","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/sj.onc.1203486","article-title":"STAT signaling in the pathogenesis and treatment of leukemias","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.01.022_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CAD.0000000000000568","article-title":"Histone deacetylase inhibitor BG45-mediated HO-1 expression induces apoptosis of multiple myeloma cells by the JAK2\/STAT3 pathway","volume":"29","author":"Tang","year":"2018","journal-title":"Anti-Cancer Drugs"},{"issue":"11","key":"10.1016\/j.lfs.2019.01.022_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1593\/neo.121358","article-title":"Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation","volume":"14","author":"Elguero","year":"2012","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.lfs.2019.01.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.lfs.2019.01.022_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbrc.2014.08.131","article-title":"Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance","volume":"452","author":"Han","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2019.01.022_bb0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"Keeton","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2019.01.022_bb0135","series-title":"Mouse Models for Drug Discovery. Methods and Protocols","first-page":"4371","volume":"36(8)","year":"2016"},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0140","first-page":"2191","article-title":"MicroRNA143 increases cell apoptosis in myelodysplastic syndrome through the Fas\/FasL pathway both in vitro and in vivo","volume":"53","author":"Cui","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2019.01.022_bb0145","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1541-7786.MCR-06-0388","article-title":"Pim-1 kinase-dependent phosphorylation of p21Cip1\/WAF1 regulates its stability and cellular localization in H1299 cells","volume":"5","author":"Zhang","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.01.022_bb0150","first-page":"211","article-title":"Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)","volume":"11","author":"Gra\u00f1a","year":"1995","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.01.022_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1747-1028-1-25","article-title":"Regulation of CDK4","volume":"1","author":"Bockstaele","year":"2006","journal-title":"Cell Div"},{"key":"10.1016\/j.lfs.2019.01.022_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.immunol.17.1.331","article-title":"Tumor necrosis factor receptor and Fas signaling mechanisms","volume":"17","author":"Wallach","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lfs.2019.01.022_bb0175","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2019.01.022_bb0180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejmech.2014.10.064","article-title":"Design, synthesis and in vitro antitumor activity of novel N\u2011substituted\u20114\u2011phenyl\/benzylphthalazin\u20111\u2011ones","volume":"89","author":"Eldehna","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2019.01.022_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopha.2018.06.116","article-title":"Anticancer effect of the water extract of a commercial Spirulina (Arthrospira platensis) product on the human lung cancer A549 cell line","volume":"106","author":"Czerwonka","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0190","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/febs.13633","article-title":"Potential crosstalk of the interleukin\u20116\u2011heme oxygenase\u20111\u2011dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells","volume":"283","author":"Wu","year":"2016","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.lfs.2019.01.022_bb0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/CAD.0000000000000068","article-title":"Crucial role of heme oxygenase\u20111 in the sensitivity of acute myeloid leukemia cell line Kasumi\u20111 to ursolic acid","volume":"25","author":"Ma","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.lfs.2019.01.022_bb0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.lfs.2018.06.004","article-title":"Up-regulation of HO-1 promotes resistance of B-cell acute lymphocytic leukemia cells to HDAC4\/5 inhibitor LMK-235 via the Smad7 pathway","volume":"207","author":"Guo","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.lfs.2019.01.022_bb0205","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.18632\/oncotarget.1805","article-title":"Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia","volume":"5","author":"Cerny-Reiterer","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lfs.2019.01.022_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2015.06.005","article-title":"Activity of the type II JAK2 inhibitor CHZ868 in B cell acute lymphoblastic leukemia","volume":"28","author":"Wu","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.lfs.2019.01.022_bb0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1074-7613(00)80145-4","article-title":"Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis","volume":"11","author":"Shirogane","year":"1999","journal-title":"Immunity"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:44:36Z","timestamp":1565214276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":43,"alternative-id":["S0024320519300311"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.022","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2\/STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}